story of the week
The SONIA Study Protocol: Positioning of CDK4/6 Inhibitors in HR+ Advanced Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
BMC Cancer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Selecting the Optimal Position of CDK4/6 Inhibitors in Hormone Receptor-Positive Advanced Breast Cancer—The SONIA Study: Study Protocol for a Randomized Controlled Trial
BMC Cancer 2018 Nov 20;18(1)1146, A van Ommen-Nijhof, IR Konings, CJJ van Zeijl, CA Uyl-de Groot, V van der Noort, A Jager, GS SonkeFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.